NCT03567551 - Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

January 13, 2020

Study Completion Date

September 15, 2021

Conditions

Preeclampsia

Interventions

OTHER

Women w/ Preeclampsia w/o Visual Disturbances or Headache

Up to three maternal blood samples collected from each participant, cerebrospinal fluid collected from each participant during spinal or combined spinal/epidural anesthesia, one umbilical cord blood sample obtained from each participant, four placenta samples obtained from each placenta from each participant

OTHER

Women w/ Preeclampsia w/ Visual Disturbances or Headaches

Up to three maternal blood samples collected from each participant, cerebrospinal fluid collected from each participant during spinal or combined spinal/epidural anesthesia, one umbilical cord blood sample obtained from each participant, four placenta samples obtained from each placenta from each participant

OTHER

Women w/o Preeclampsia

Up to three maternal blood samples collected from each participant, cerebrospinal fluid collected from each participant during spinal or combined spinal/epidural anesthesia, one umbilical cord blood sample obtained from each participant, four placenta samples obtained from each placenta from each participant

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham